Instrument Inactif

Communiqués IMCLONE SYSTEMS Nasdaq

Actions

US45245W1099

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

30/11/-1	ImClone : accord de rachat par Eli Lilly pour 6,5 Mds$.
30/11/-1	ImClone : un groupe pourrait faire une proposition de rachat.

Communiqués

30/11/-1	IMCLONE SYSTEMS : Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share	PR
30/11/-1	IMCLONE SYSTEMS : Icahn Responds to Cornelius	PR
30/11/-1	Imclone Systems : Seven Summits Research Releases Comments on QCOM, NOK, BUD, COF, and IMCL	PR
30/11/-1	Imclone Systems : ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at the Bear Stearns Annual Healthcare Conference	BU
30/11/-1	Imclone Systems : Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment	BU
30/11/-1	Imclone Systems : Phase II Study of IMC-1121B for Advanced Renal Cell Cancer Opens for Patient Enrollment	BU
30/11/-1	Imclone Systems : FDA Approves ImClone Systems' New State-of-the-Art Manufacturing Facility	BU
30/11/-1	Imclone Systems : ImClone Systems Appoints John H. Johnson Chief Executive Officer	BU
30/11/-1	Imclone Systems : Phase II Study of IMC-11F8 for Advanced Colorectal Cancer Has Commenced Patient Enrollment in Europe	BU
30/11/-1	Imclone Systems : ImClone Systems Reports Second Quarter 2007 Financial Results	BU
30/11/-1	Imclone Systems : ImClone Systems to Host 2007 Second Quarter Financial Results Conference Call	BU
30/11/-1	Imclone Systems : ImClone Systems to Host Annual Meeting of Stockholders on August 2, 2007	BU
30/11/-1	Imclone Systems : Phase II Study of IMC-A12 for Advanced Colorectal Cancer Has Commenced Patient Enrollment	BU
30/11/-1	Imclone Systems : ImClone Systems Appoints Thomas F. Deuel to Board of Directors	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at the Goldman Sachs 28th Annual Global Health Care Conference	BU
30/11/-1	Imclone Systems : FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at the Bear Stearns Third Annual Biotech Confab	BU
30/11/-1	Imclone Systems : Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting	BU
30/11/-1	Imclone Systems : Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO	BU
30/11/-1	Imclone Systems : Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO	BU
30/11/-1	Imclone Systems : ImClone Systems to Host Investor Reception on June 5, 2007 Following a Clinical Science Symposium Session about EGFR as a Therapeutic Target in GI Malignancy	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at the Friedman, Billings, Ramsey & Co. Growth Conference and the Bank of America Health Care Conference	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at the Citigroup 2007 Healthcare Conference	BU
30/11/-1	Imclone Systems : ImClone Systems to Present at The Rodman & Renshaw Fourth Annual Global Healthcare Conference	BU